Clinical Trials Logo

Clinical Trial Summary

The proposed study will establish the feasibility, acceptability and credibility of a novel live video dyadic resiliency intervention, Resilient Together for Dementia (RT-D), aimed at preventing chronic emotional distress and preserving quality of life among dyads at risk for chronic emotional distress early after a diagnosis of Alzheimer's disease or a related dementia (ADRD).


Clinical Trial Description

Both persons living with dementia (PWDs) and their spousal care-partners experience high levels of clinically elevated emotional distress, which can become chronic without treatment and negatively impact the health, quality of life, communication, and care-planning of both partners. A tailored dyadic intervention, such as the proposed Resilient Together for Dementia, delivered over live video to this at risk population during the window of opportunity when PWDs can participate has the potential to prevent chronic emotional distress and preserve quality of life for PWDs and their loved ones. In the Intervention Phase (Aims 2 and 3), an open pilot (N=5 dyads) of the newly developed RT-D followed by exit interviews will be conducted to explore the initial feasibility and acceptability of the adapted protocol and to further refine the intervention content, materials, and procedures (Aim 2; NIA Stage 1A). Next, a pilot feasibility randomized control trial (RCT; Aim 3; NIA Stage 1B; N=50 dyads) will be conducted of the refined RT-D versus a minimally enhanced educational control (MEUC). Primary outcomes will be feasibility, credibility, and acceptability markers to inform a hybrid efficacy effectiveness R01 (year 4) of RT-D vs. MEUC (NIA Stage III). In this subsequent R01, the researcher will examine RT-D's impact on emotional distress and quality of life outcomes and test mechanisms of change (individual and interpersonal resiliency skills) through mediation and moderation. The researcher will revise the approach if feasibility benchmarks are not met. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06421545
Study type Interventional
Source Icahn School of Medicine at Mount Sinai
Contact Sarah M Bannon, PhD
Phone 212-241-0787
Email sarah.bannon@montsinai.org
Status Recruiting
Phase N/A
Start date April 19, 2024
Completion date September 2024

See also
  Status Clinical Trial Phase
Completed NCT04457973 - Home-based Transcranial Direct Current Stimulation for Pain Management in Persons With Alzheimer's Disease and Related Dementias N/A
Completed NCT04857060 - Palliative Care Educator N/A
Recruiting NCT05719077 - Pilot Testing Dementia-Enhanced Training and Tool for Home Hospice Clinicians N/A
Completed NCT04179721 - Reducing Behavioral and Psychological Symptoms of Dementia: Hospital Caregivers (Aim 2) N/A
Recruiting NCT06335953 - ALIGN: Aligning Medications With What Matters Most (Demonstration) N/A
Completed NCT05255068 - OPTIMAL in NH Residents With Dementia N/A
Recruiting NCT06276023 - Supporting Our Caregivers In ADRD Learning (SOCIAL) N/A
Recruiting NCT05877391 - Intervention to Collect and Utilize Sexual Orientation and Gender Identity (SOGI) Information in Hospice
Completed NCT01498263 - Inherited Diseases, Caregiving, and Social Networks
Completed NCT04481568 - Reducing Behavioral and Psychological Symptoms of Dementia: Family Caregivers (Aim 1) N/A
Recruiting NCT03848312 - Preventing Alzheimer's With Cognitive Training Phase 3
Recruiting NCT05825404 - Smart Lighting for Nursing Home Residents With Dementia N/A
Not yet recruiting NCT05942040 - Translating Data Science to Palliative Care N/A